TrialCancer research communications2026

Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.